These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6390960)

  • 21. [Prevention of stress-induced dyslipidemia by adaptation to short-term exposure to stress].
    Meerson FZ; Tverdokhlib VP; Lobanova GT; Golubeva LIu; Nikonorov AA
    Fiziol Zh (1978); 1987; 33(6):3-8. PubMed ID: 3446522
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hyperlipidemia and atherosclerosis: epidemiology, biochemistry and therapy].
    Ducobu J; Berghmans L; Carpentier YA; Daubresse JC; Kornitzer M; Balasse E
    Rev Med Brux; 1993 Oct; 14(8):239-45. PubMed ID: 8272680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current problems in the etiopathogenesis of atherosclerosis].
    Creţeanu G; Mungiu OC; Hurjui J; Creţeanu M; Creţeanu G
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(1):109-12. PubMed ID: 4070862
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of hypokinesia on the indicators of the antioxidant system and free-radical oxidation in rats].
    Brechko VV
    Patol Fiziol Eksp Ter; 1983; (5):56-9. PubMed ID: 6685862
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of antioxidants in chronic nonspecific lung diseases (a review of the literature)].
    Redchits IV; Selikhova LG; Gol'denberg IuM; Vasylyk AT; Kachura GA
    Vrach Delo; 1986 Nov; (11):8-11. PubMed ID: 3548060
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypothetical connection between diabetes mellitus and free radical reactions in arteriosclerosis].
    Somogyi A; Pusztai P; Prechl J; Fehér J
    Orv Hetil; 1994 Aug; 135(33):1815-8. PubMed ID: 8072757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of free radical oxidation processes in the morphogenesis of axons of regenerating nerves].
    Radlinskaia VN; Voskresenskiĭ ON; Bobyrev VN; Zhutaev IA
    Vopr Med Khim; 1986; 32(6):58-60. PubMed ID: 3811288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular action of alpha-tocopherol in lipoprotein lipid peroxidation. Pro- and antioxidant activity of vitamin E in complex heterogeneous lipid emulsions.
    Witting PK; Upston JM; Stocker R
    Subcell Biochem; 1998; 30():345-90. PubMed ID: 9932522
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biochemical and experimental aspects of the lipid-lowering drugs pharmacology (author's transl)].
    Jacotot B
    Pathol Biol (Paris); 1979 May; 27(5):305-13. PubMed ID: 388303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression of atherosclerosis.
    Garber AJ
    Curr Ther Endocrinol Metab; 1994; 5():484-91. PubMed ID: 7704778
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lipid peroxides and atherosclerosis. Hypothesis: the role of cholesterol and free-radical lipid peroxidation in altering cell membrane properties in hypercholesterolemia and atherosclerosis].
    Lankin VZ
    Kardiologiia; 1980 Aug; 20(8):42-8. PubMed ID: 7412095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies.
    Daugherty A; Roselaar SE
    Cardiovasc Res; 1995 Mar; 29(3):297-311. PubMed ID: 7781006
    [No Abstract]   [Full Text] [Related]  

  • 34. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance.
    Stocker R
    Curr Opin Lipidol; 1994 Dec; 5(6):422-33. PubMed ID: 7712047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cholesterol oxidation, macrophage foam cells and atherosclerosis: importance of antioxidants and paraoxonase].
    Aviram M
    Harefuah; 1999 Apr; 136(8):620-6. PubMed ID: 10955072
    [No Abstract]   [Full Text] [Related]  

  • 36. [The use of alisat for correction of level of lipids and their peroxidation products in blood of patients with atherosclerosis].
    Mikhin VP
    Biull Eksp Biol Med; 1998 Sep; 126(9):345-9. PubMed ID: 9805629
    [No Abstract]   [Full Text] [Related]  

  • 37. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats.
    Deepa PR; Varalakshmi P
    Clin Chim Acta; 2005 May; 355(1-2):119-30. PubMed ID: 15820486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Verification of the lipid hypothesis by drug intervention].
    Levy RI
    Ter Arkh; 1985; 57(11):33-5. PubMed ID: 3909475
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experimental peroxide atherosclerosis in rabbits].
    Voskresenskiĭ ON; Bobyrev VN
    Vopr Pitan; 1981; (3):42-5. PubMed ID: 7269447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An increase in lipoprotein oxidation and endogenous lipid peroxides in serum of obese women.
    Mutlu-Türkoğlu U; Oztezcan S; Telci A; Orhan Y; Aykaç-Toker G; Sivas A; Uysal M
    Clin Exp Med; 2003 Feb; 2(4):171-4. PubMed ID: 12624707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.